Welcome to our dedicated page for Cannabist SEC filings (Ticker: CBSTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cannabist’s expanding footprint spans cultivation sites, dispensaries, and compliance technology—yet its SEC paperwork can feel denser than the regulations it navigates. If you’ve ever searched for “Cannabist SEC filings explained simply” only to meet hundreds of pages of cross-referenced cannabis statutes, you know the pain.
Stock Titan solves that problem. Our AI reads every Cannabist quarterly earnings report 10-Q filing, Cannabist annual report 10-K simplified, and sudden Cannabist 8-K material events explained, then highlights licensing wins, segment EBITDA, and cash burn in plain English. Need to watch management sentiment? Receive Cannabist Form 4 insider transactions real-time alerts and dive into Cannabist executive stock transactions Form 4 without hunting through EDGAR. From Cannabist earnings report filing analysis to the latest Cannabist proxy statement executive compensation, every document updates the moment it hits the SEC’s servers.
Whether you’re modeling wholesale price trends or gauging how fast new retail locations lift revenue, our platform turns regulations into insights. Use AI-powered summaries to spot state-by-state license exposure, compare quarter-over-quarter cultivation yields, or track Cannabist insider trading Form 4 transactions ahead of ballot initiatives. Understanding Cannabist SEC documents with AI isn’t a luxury—it's how professionals stay ahead.
The Cannabist Company Holdings Inc. (CBSTF) reported that its Chief Financial Officer, Derek Watson, resigned his employment position on November 15, 2025 but will continue to serve as CFO as a non-employee consultant. The company states that his transition is not due to any disagreement over its financial statements, internal controls, operations, policies or practices.
Under a new CFO Consulting Agreement, Mr. Watson will allocate a minority of his working time to the company and receive $15,000 per month. He remains eligible for the 2025 executive bonus plan based on performance from January 1, 2025 to November 15, 2025. The consulting term runs from November 16, 2025 to May 15, 2026 and can be ended by either party, with the company able to pay an amount equal to two months of fees in lieu of notice.
The Cannabist Company Holdings Inc. furnished a current report to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1.
The information under Item 2.02 and Exhibit 99.1 is being furnished, not deemed filed under the Exchange Act or incorporated by reference unless expressly stated.
The Cannabist Company Holdings Inc. reported Q3 results with revenues of $79.9 million, down from $114.8 million a year ago, and a net loss of $14.7 million. For the first nine months of 2025, revenue was $253.7 million and net loss was $124.2 million.
The company disclosed substantial doubt about its ability to continue as a going concern, citing ongoing losses, negative operating cash flow of $35.7 million year‑to‑date, and limited liquidity with cash and restricted cash of $20.9 million at quarter end. Total equity was $(152.9) million, reflecting liabilities in excess of assets.
Management completed a 2025 debt transaction, exchanging 2025, 2026 and 2027 notes into 9.25% Senior Secured Notes due 2028 and 9.0% 2028 convertible notes, and issued 118,246,947 warrants. Long‑term debt, net, stood at $298.7 million. The company continued portfolio rationalization, recording gains and losses on divestitures, and ended the quarter with 491,976,807 common shares outstanding.
Cannabist Co Holdings Inc. (CBSTF) reported a grant of 1,545,455 restricted stock units (RSUs) to director Julie A. Hill on 10/01/2025. Each RSU represents the contingent right to one share of the issuer's common stock and the reported grant carries a $0 purchase price. The RSUs will vest on the date of the issuer's 2026 annual meeting, and settlement is to occur as soon as administratively feasible following vesting. Following the grant, Ms. Hill is reported to beneficially own 1,545,455 shares directly.
Jonathan P. May, a director of Cannabist Co Holdings Inc. (CBSTF), was granted 1,545,455 restricted stock units (RSUs) on 10/01/2025. Each RSU represents a contingent right to one share of the issuer's common stock and carries an effective price of $0. The RSUs will vest on the date of the issuer's 2026 annual meeting, and settlement will occur as soon as administratively feasible after vesting. Following the grant, the reported number of common shares beneficially owned is 1,545,455 held directly. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Jeff Clarke, a director of Cannabist Co Holdings Inc. (CBSTF), was granted 1,545,455 restricted stock units (RSUs) on 10/01/2025. Each RSU represents a contingent right to receive one share of the issuer's common stock, and the RSUs will vest on the date of the issuer's 2026 annual meeting. Settlement of the vested RSUs will occur as soon as administratively feasible following vesting. The report shows 1,545,455 common shares beneficially owned following the transaction, held in a direct ownership form, with a reported per-unit price of $0.
Cannabist Co Holdings Inc. insider David Sirolly, the company's Chief Legal Officer and General Counsel, reported a transaction dated 09/30/2025 on SEC Form 4. The filing shows 962 common shares were acquired at an effective price of $0.073 per share under transaction code F. The form's explanatory note states these shares represent amounts withheld by the issuer to satisfy tax obligations at the time of share settlement for annual equity grants. After this activity, Mr. Sirolly beneficially owns 1,130,779 common shares. The Form 4 is individually filed and is signed by Mr. Sirolly on 10/02/2025.
Cannabist Co Holdings Inc. (CBSTF) reporting person Rosemary Mazanet notified the company that she ceased to be a director on September 24, 2025. The Form 4 contains no reported purchases or sales of issuer securities; the filing is signed by an attorney-in-fact on behalf of Ms. Mazanet on September 26, 2025.
FAQ
What is the current stock price of Cannabist (CBSTF)?
What is the market cap of Cannabist (CBSTF)?
